Certis Therapeutics, a spin-off of IHU Liryc, raises €1.5 million to commercialize its first medical devices.

The specialist in mini-invasive MRI guided therapies, created two years ago, has just concluded its fundraising with Medevice lead (Medevice Capital III), as well as regional funds Aquiti Gestion (NACO), GSO Innovation and Crédit Agricole Aquitaine Expansion. The funds raised will be used to finance the next milestone in the development of Certis Therapeutics.

Click here to access the press release.